Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29602465 | 0.98 | TYMS (0.48) | TYMSDHFR | |
| SCHEMBL21161374 | 0.87 | TYMS (0.49) | TYMSDHFR | |
| SCHEMBL14453489 | 0.83 | TYMS (0.47) | TYMSDHFR | |
| SCHEMBL21067593 | 0.79 | TYMS (0.55) | TYMSDHFR | |
| SCHEMBL22967337 | 0.78 | TYMS (0.59) | TYMSDHFR | |
| SCHEMBL19929245 | 0.78 | PNP (0.48) | TYMS | |
| SCHEMBL18520454 | 0.77 | DYRK1A (0.47) | TYMS | |
| SCHEMBL19929242 | 0.77 | TYMS (0.51) | TYMSDHFR | |
| SCHEMBL21187099 | 0.77 | TYMS (0.46) | TYMSDHFR | |
| SCHEMBL17662614 | 0.76 | PNP (0.46) | TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 886 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559745-B2 | Methods and compositions for linking RNA stem loops | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-24 | — | — | US | claimed |
| US-12473573-B2 | Switchable Cas9 nucleases and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-11-18 | — | — | US | claimed |
| EP-4600362-A1 | REPORTER GENE CONSTRUCT SENSITIVE TO QUEUOSINE LEVELS | Instituto Nacional de Técnica Aeroespacial "Esteban Terradas" (ES) | 2025-08-13 | — | — | EP | claimed |
| WO-2025075256-A1 | APPARATUS AND METHOD FOR EARLY DISEASE DETECTION BASED ON HIGH-DEPTH CELL-FREE NUCLEIC ACID SEQUENCING | (주)지놈포미 | 2025-04-10 | — | — | WO | claimed |
| CN-119563035-A | Method for screening compounds | 德皮克萨斯股份有限公司 | 2025-03-04 | — | — | CN | claimed |
| US-20250019719-A1 | Purification and Purity Assessment of RNA Molecules Synthesized with Modified Nucleosides | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2025-01-16 | — | — | US | claimed |
| US-20240417780-A1 | DETECTION OF NUCLEIC ACID AND NON-NUCLEIC ACID TARGET MOLECULES | VEDABIO, INC. | 2024-12-19 | — | — | US | claimed |
| US-12117442-B2 | Methods of screening compounds | Depixus SAS (FR) | 2024-10-15 | — | — | US | claimed |
| US-12091707-B2 | Detection of nucleic acid and non-nucleic acid target molecules | VEDABIO, INC. (US) | 2024-09-17 | — | — | US | claimed |
| EP-4426720-A1 | MODIFIED MRNA THERAPEUTICS | Shattuck Labs, Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| CN-116985675-A | External discharge control method and device and automobile | 赛力斯汽车有限公司 | 2023-11-03 | — | — | CN | claimed |
| EP-4217490-A2 | PRIME EDITING GUIDE RNAS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | The Broad Institute Inc. (US) | 2023-08-02 | — | — | EP | claimed |
| WO-2023077156-A1 | MODIFIED MRNA THERAPEUTICS | SHATTUCK LABS, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| WO-2022251242-A1 | COMPOSITIONS AND METHODS FOR MODIFYING DNA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-12-01 | — | — | WO | claimed |
| CN-113555910-B | Energy microgrid system with intelligent hydroelectric energy storage equipment | 江苏大学 | 2022-06-21 | — | — | CN | claimed |
| CN-113022344-B | Power battery charging system based on double motors and electric automobile | 重庆长安新能源汽车科技有限公司 | 2022-05-31 | — | — | CN | claimed |
| WO-2022109495-A1 | METHODS AND COMPOSITIONS FOR LINKING RNA STEM LOOPS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-05-27 | — | — | WO | claimed |
| US-20220145308-A1 | MATERIALS AND METHODS FOR REDUCING NUCLEIC ACID DEGRADATION IN BACTERIA | NATIONAL INSTITUTES OF HEALTH | 2022-05-12 | — | — | US | claimed |
| WO-2022067130-A2 | PRIME EDITING GUIDE RNAS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | THE BROAD INSTITUTE, INC. (US) | 2022-03-31 | — | — | WO | claimed |
| US-11267842-B2 | Enzymatic modification of nucleic acids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-03-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11267842-B2 | Enzymatic modification of nucleic acids | RNGTT, UNG, RNASEL | TYMS 172/4885DHFR 251/4885 |
| US-12559745-B2 | Methods and compositions for linking RNA stem loops | TRDMT1, NSUN3, TRMT1L | TYMS 51/4885DHFR 1223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.